FHTX (FHTX) Stock Price & Analysis
FHTX (FHTX) fell 2.24% to USD 4.81 as of September 8, 2026 at 14:53 UTC, according to Nexqual real-time market data.
FHTX last closed at USD 4.81; the session ranged USD 4.67–4.89 on volume of 41,556 shares. Market capitalization is —, with a 52-week range of USD 3.27–7.61 (NGM). Source: Nexqual, September 8, 2026 at 14:53 UTC.
Key Statistics (as of September 8, 2026 at 14:53 UTC)
| Price | USD 4.81 |
|---|---|
| Change | ▼ 2.24% (down) |
| Previous Close | USD 4.81 |
| Open | USD 4.81 |
| Day Range | USD 4.67 – 4.89 |
| 52-Week Range | USD 3.27 – 7.61 |
| Volume | 41,556 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (FHTX)
Nexqual's technical model rates FHTX "SELL" based on 1 bullish and 5 bearish signals across 127 daily candles, as of September 8, 2026 at 14:53 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 32.31 (neutral) |
| vs SMA50 | Below (USD 5.65) |
| MACD | -0.16 (negative) |
From FHTX's Latest SEC 10-K Filing (filed 2026-03-11)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PRLD | Prelude Therapeutics Incorporat | USD 5.31 | ▲ 1.14% |
| CCCC | C4 Therapeutics, Inc. | USD 3.67 | ▼ 2.01% |
| STTK | Shattuck Labs, Inc. | USD 6.77 | ▼ 2.73% |
| CGEM | Cullinan Therapeutics, Inc. | USD 21.69 | ▼ 2.12% |
| KYMR | Kymera Therapeutics, Inc. | USD 119.3 | ▲ 1.72% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 14:53 UTC. This page is informational and not investment advice.